<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    AcelRx Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About AcelRx Pharmaceuticals, Inc.

    AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $95,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Vincent J. Angotti
    • FOUNDED
      2005
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    National Research Corporation

    National Research Corporation

    NRC Health is one of the nation’s largest healthcare performance improvement fir...

    NRC Health is one of the nation’s largest hea...

    Filing Type:    PU
    Five Star Senior Living Inc.

    Five Star Senior Living Inc.

    Five Star Senior Living Inc. is a senior living and healthcare services company. A...

    Five Star Senior Living Inc. is a senior living...

    Filing Type:    PU
    Betterpath, Inc.

    Betterpath, Inc.

    Betterpath makes the benefit of health data ownership clear, reconciling crucial s...

    Betterpath makes the benefit of health data own...

    Amount Raised:    $8,800,000
    Fundraising Status:    EC
    Filing Type:    CF
    ImmunoGen, Inc.

    ImmunoGen, Inc.

    ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to ...

    ImmunoGen is developing the next generation of ...

    Filing Type:    PU
    Neurocarrus Inc

    Neurocarrus Inc

    Neurocarrus is developing a breakthrough therapy ( N-001 ) to fulfill the unmet ne...

    Neurocarrus is developing a breakthrough therap...

    Amount Raised:    $344,168.00
    Fundraising Status:    EC
    Filing Type:    CF
    Miragen Therapeutics, Inc.

    Miragen Therapeutics, Inc.

    miRagen Therapeutics, Inc., is a clinical stage biopharmaceutical company discover...

    miRagen Therapeutics, Inc., is a clinical stage...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.